FeesSafety
Pluang+

Celestia's TIA token demand depends on real rollup usage, not speculation, amid growing modular blockchain competition.

Protocol Fundamentals
25 May 2026, 09:12 WIB
Crypto Daily
View Source
Neutral
Celestia's TIA token demand depends on real rollup usage, not speculation, amid growing modular blockchain competition.

Celestia specializes in data availability for modular blockchains, with its TIA token fueling economic activity. The token's sustainable demand hinges on rollups consistently paying fees to publish data blobs on Celestia, distinguishing real usage from speculative trading. Key metrics to watch include blob volume, fees paid, and repeat rollup integrations. Celestia faces competition from Ethereum's EIP-4844, EigenDA, and Avail, each offering different trade-offs in cost, trust, and throughput. Builders and investors should focus on on-chain fee revenue, validator decentralization, and live integrations to assess Celestia's long-term viability and TIA's utility beyond market hype.

More News

Danske Bank buys back 25,000 shares in week 46, continuing its DKK 4.5 billion buy-back program.

Danske Bank buys back 25,000 shares in week 46, continuing its DKK 4.5 billion buy-back program.

Danske Bank executed transactions to repurchase 25,000 shares during week 46 as part of its ongoing share buy-back program announced in February 2026. The program targets a total buy-back of up to DKK 4.5 billion or 45 million shares by January 2027....

Company Fundamentals
Neutral
21 minutes ago
French firms boost AI-driven cybersecurity, focusing on productivity and operational results over processes.

French firms boost AI-driven cybersecurity, focusing on productivity and operational results over processes.

A new study by Securonix shows French organizations are increasingly adopting AI-driven cybersecurity operations, prioritizing productivity and measurable outcomes rather than just processes. French firms lead in allowing AI to automatically trigger ...

Market News
Neutral
1 hour ago
Lakefront Biotherapeutics launches new €50M share buyback after completing initial program

Lakefront Biotherapeutics launches new €50M share buyback after completing initial program

Lakefront Biotherapeutics has started a new €50 million share buyback program following the completion of its initial €50 million program, in which it repurchased about 1.99 million shares. The new program, running until March 31, 2027, aims to enhan...

Company Fundamentals
Bullish
2 hours ago
Exosens wins order for 25,000 image intensifier tubes to boost European night vision tech.

Exosens wins order for 25,000 image intensifier tubes to boost European night vision tech.

Exosens secured a firm order to supply 25,000 high-performance 4G+ image intensifier tubes to Theon Sensors for integration into night vision devices, with deliveries starting late 2026. This order is part of a long-term agreement through 2030 and in...

Market News
Bullish
3 hours ago
Exosens secures a major order for 25,000 light intensifier tubes for night vision devices through 2030.

Exosens secures a major order for 25,000 light intensifier tubes for night vision devices through 2030.

Exosens has received a firm order for 25,000 high-performance 4G+ light intensifier tubes to equip night vision products for Theon, under a long-term supply agreement extended through 2030. The order includes options for an additional 35,000 tubes, p...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App